Ep. 236: “ISSCR 2023: The Future Starts Here” Featuring Keith Alm, Dr. Haifan Lin, and Dr. David Scadden
The Stem Cell Podcast
00:00
I'll Let You Do That. I Don't Do So. I Do So
The key here is motor neuron loss paralysis. Within two to five years of onset, most of these patients are dead. There's no real therapies because there's a lot of diverse etiologies. So one of the toughest things and the greatest goals has been to find pathways that will work for multiple forms of ALS.
Transcript
Play full episode
